| |
|
|
|
Caladrius Biosciences Inc.  
|
|
4.69 0.14 (0.03%) |
10-17 14:25 |
|
Open: |
4.51 |
Pre close: |
4.55 |
Target:
|
6.85
|
|
High: |
4.8199 |
Low: |
4.51 |
Resistance:
|
5.86
6.83
|
|
Volume: |
10,454 |
Market Cap: |
46M |
Support:
|
4.30
3.58
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.73
 |
MACD |
MACD(12,26):
|
-0.25 |
|
MA(20): |
5.41 |
Signal(12,26,9): |
-0.15 |
|
MA(100): |
5.32  |
Stochastic Oscillator |
%K(14,3):
|
16.33 |
|
MA(250): |
4.61 |
%D(3): |
17.72 |
|
Average Volume(K) |
3-Month: |
3841
|
52-Week |
High:
|
11.65 |
|
10-Days: |
4416 |
Low: |
2.63 |
|
RSI |
RSI(14):
|
42.10 |
Change(%): |
39.1 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.720 |
Return on Equity (ttm) |
-31.1 |
Shares Out. (M) |
9.73 |
|
EPS Est. Current Year |
-2.420 |
Return on Assets (ttm) |
-24.5 |
Shares Float (M) |
1.86 |
|
EPS Est. Next Year |
-2.950 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.770 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
6.30 |
|
Forward EPS |
1.#IO |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
46 |
|
Book Value (p.s.) |
1.070 |
EBITDA (p.s.) |
-0.603 |
P/E |
-2.77 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
4.45 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
0.00 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
0.00 |
P/CF |
0.00 |
|
|
|
|
|
|
